TGTX logo

TG Therapeutics, Inc. (TGTX) Operating expenses

annual operating expenses:

$248.59M+$49.69M(+24.98%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TGTX annual total operating expenses is $248.59 million, with the most recent change of +$49.69 million (+24.98%) on December 31, 2024.
  • During the last 3 years, TGTX annual operating expenses has fallen by -$102.08 million (-29.11%).
  • TGTX annual operating expenses is now -29.11% below its all-time high of $350.67 million, reached on December 31, 2021.

Performance

TGTX Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

quarterly operating expenses:

$87.31M-$9.33M(-9.65%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TGTX quarterly total operating expenses is $87.31 million, with the most recent change of -$9.33 million (-9.65%) on June 30, 2025.
  • Over the past year, TGTX quarterly operating expenses has increased by +$31.03 million (+55.15%).
  • TGTX quarterly operating expenses is now -9.65% below its all-time high of $96.64 million, reached on March 31, 2025.

Performance

TGTX quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

TGTX Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.0%+55.1%
3 y3 years-29.1%+121.7%
5 y5 years+46.9%+71.9%

TGTX Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-29.1%+25.0%-9.7%+150.0%
5 y5-year-29.1%+46.9%-9.7%+150.0%
alltimeall time-29.1%>+9999.0%-9.7%+5120.3%

TGTX Operating expenses History

DateAnnualQuarterly
Jun 2025
-
$87.31M(-9.7%)
Mar 2025
-
$96.64M(+53.9%)
Dec 2024
$248.59M(+25.0%)
$62.77M(+1.2%)
Sep 2024
-
$62.04M(+10.2%)
Jun 2024
-
$56.27M(-16.3%)
Mar 2024
-
$67.22M(+38.6%)
Dec 2023
$198.90M(-9.9%)
$48.51M(+2.4%)
Sep 2023
-
$47.40M(-19.3%)
Jun 2023
-
$58.75M(+34.1%)
Mar 2023
-
$43.82M(-15.8%)
Dec 2022
$220.84M(-37.0%)
$52.01M(+48.9%)
Sep 2022
-
$34.93M(-11.3%)
Jun 2022
-
$39.38M(-42.6%)
Mar 2022
-
$68.65M(-27.8%)
Dec 2021
$350.67M(+28.1%)
$95.06M(+9.4%)
Sep 2021
-
$86.87M(+10.1%)
Jun 2021
-
$78.89M(-12.2%)
Mar 2021
-
$89.86M(+3.6%)
Dec 2020
$273.75M(+61.8%)
$86.71M(+1.2%)
Sep 2020
-
$85.67M(+68.7%)
Jun 2020
-
$50.79M(+5.4%)
Mar 2020
-
$48.20M(+25.4%)
Dec 2019
$169.21M(-3.1%)
$38.43M(-36.9%)
Sep 2019
-
$60.87M(+71.2%)
Jun 2019
-
$35.56M(+2.5%)
Mar 2019
-
$34.70M(-35.9%)
Dec 2018
$174.55M(+46.9%)
$54.16M(+57.7%)
Sep 2018
-
$34.34M(-22.6%)
Jun 2018
-
$44.36M(+6.7%)
Mar 2018
-
$41.59M(+34.0%)
Dec 2017
$118.86M(+50.2%)
$31.05M(-1.7%)
Sep 2017
-
$31.60M(+11.1%)
Jun 2017
-
$28.44M(+2.7%)
Mar 2017
-
$27.68M(+15.1%)
Dec 2016
$79.12M(+24.9%)
$24.05M(-3.6%)
Sep 2016
-
$24.94M(+55.5%)
Jun 2016
-
$16.04M(+14.4%)
Mar 2016
-
$14.02M(-20.5%)
Dec 2015
$63.33M(+13.3%)
$17.64M(+27.6%)
Sep 2015
-
$13.83M(-19.2%)
Jun 2015
-
$17.11M(+17.2%)
Mar 2015
-
$14.60M(-22.0%)
Dec 2014
$55.87M(+175.0%)
$18.72M(+7.4%)
Sep 2014
-
$17.44M(+45.9%)
Jun 2014
-
$11.96M(+57.2%)
Mar 2014
-
$7.61M(+46.9%)
Dec 2013
$20.32M(-21.3%)
$5.18M(+11.4%)
Sep 2013
-
$4.65M(-29.9%)
Jun 2013
-
$6.63M(+78.5%)
Mar 2013
-
$3.71M(+43.6%)
Dec 2012
$25.81M(+2826.2%)
$2.59M(-4.7%)
Sep 2012
-
$2.71M(-12.6%)
Jun 2012
-
$3.10M(-82.1%)
Mar 2012
-
$17.39M(+6545.8%)
Dec 2011
$882.00K(-56.3%)
-
Sep 2011
-
$261.60K(-18.9%)
Jun 2011
-
$322.50K(-56.2%)
Mar 2011
-
$735.80K(+65.1%)
DateAnnualQuarterly
Dec 2010
$2.02M(+13.8%)
$445.80K(-13.5%)
Sep 2010
-
$515.60K(-1.8%)
Jun 2010
-
$525.10K(-0.8%)
Mar 2010
-
$529.40K(+55.1%)
Dec 2009
$1.77M(-59.9%)
$341.30K(-13.7%)
Sep 2009
-
$395.60K(-17.1%)
Jun 2009
-
$477.30K(-14.4%)
Mar 2009
-
$557.30K(+965.6%)
Dec 2008
$4.41M(-63.7%)
$52.30K(-96.2%)
Sep 2008
-
$1.38M(-5.7%)
Jun 2008
-
$1.47M(-9.1%)
Mar 2008
-
$1.61M(-15.9%)
Dec 2007
$12.14M(+21.4%)
$1.92M(-29.1%)
Sep 2007
-
$2.71M(-45.0%)
Jun 2007
-
$4.92M(+89.8%)
Mar 2007
-
$2.59M(-18.4%)
Dec 2006
$10.00M(-48.3%)
$3.18M(+61.8%)
Sep 2006
-
$1.97M(-16.6%)
Jun 2006
-
$2.36M(-19.1%)
Mar 2006
-
$2.91M(+11.0%)
Dec 2005
$19.36M(+215.1%)
$2.63M(+42.1%)
Sep 2005
-
$1.85M(+23.6%)
Jun 2005
-
$1.50M(+3.6%)
Mar 2005
-
$1.44M(-19.4%)
Dec 2004
$6.14M(+29.1%)
$1.79M(-20.1%)
Sep 2004
-
$2.24M(+128.3%)
Jun 2004
-
$981.80K(-12.3%)
Mar 2004
-
$1.12M(-26.3%)
Dec 2003
$4.76M(+367.3%)
$1.52M(+103.0%)
Sep 2003
-
$749.10K(+7.6%)
Jun 2003
-
$696.00K(+76.0%)
Mar 2003
-
$395.40K(+11.7%)
Dec 2002
$1.02M(-72.8%)
$354.00K(-38.5%)
Sep 2002
-
$575.20K(+26.2%)
Jun 2002
-
$455.80K(-26.3%)
Mar 2002
-
$618.40K(+13.1%)
Dec 2001
$3.74M(-16.3%)
$547.00K(-21.1%)
Sep 2001
-
$693.40K(-52.9%)
Jun 2001
-
$1.47M(+67.3%)
Mar 2001
-
$880.70K(-150.6%)
Dec 2000
$4.46M(+43.9%)
-$1.74M(-250.0%)
Sep 2000
-
$1.16M(-65.6%)
Jun 2000
-
$3.37M(+33.4%)
Mar 2000
-
$2.52M(+224.5%)
Dec 1999
$3.10M(-47.5%)
$777.60K(+54.5%)
Sep 1999
-
$503.40K(-28.4%)
Jun 1999
-
$703.10K(-24.5%)
Mar 1999
-
$931.20K(+294.7%)
Dec 1998
$5.90M(+7.3%)
$235.90K(-72.0%)
Sep 1998
-
$842.60K(-13.4%)
Jun 1998
-
$972.70K(+55.9%)
Mar 1998
-
$624.00K(-63.3%)
Dec 1997
$5.50M(+103.7%)
$1.70M(+54.5%)
Sep 1997
-
$1.10M(-38.9%)
Jun 1997
-
$1.80M(+100.0%)
Mar 1997
-
$900.00K(>+9900.0%)
Dec 1996
$2.70M
$0.00(-100.0%)
Sep 1996
-
$1.20M(+71.4%)
Jun 1996
-
$700.00K

FAQ

  • What is TG Therapeutics, Inc. annual total operating expenses?
  • What is the all time high annual operating expenses for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. annual operating expenses year-on-year change?
  • What is TG Therapeutics, Inc. quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for TG Therapeutics, Inc.?
  • What is TG Therapeutics, Inc. quarterly operating expenses year-on-year change?

What is TG Therapeutics, Inc. annual total operating expenses?

The current annual operating expenses of TGTX is $248.59M

What is the all time high annual operating expenses for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high annual total operating expenses is $350.67M

What is TG Therapeutics, Inc. annual operating expenses year-on-year change?

Over the past year, TGTX annual total operating expenses has changed by +$49.69M (+24.98%)

What is TG Therapeutics, Inc. quarterly total operating expenses?

The current quarterly operating expenses of TGTX is $87.31M

What is the all time high quarterly operating expenses for TG Therapeutics, Inc.?

TG Therapeutics, Inc. all-time high quarterly total operating expenses is $96.64M

What is TG Therapeutics, Inc. quarterly operating expenses year-on-year change?

Over the past year, TGTX quarterly total operating expenses has changed by +$31.03M (+55.15%)
On this page